MARKET

CNTB

CNTB

Connect Biopharma Holdings Ltd
NASDAQ
2.540
-0.110
-4.15%
After Hours: 2.540 0 0.00% 18:06 12/04 EST
OPEN
2.650
PREV CLOSE
2.650
HIGH
2.650
LOW
2.500
VOLUME
62.09K
TURNOVER
--
52 WEEK HIGH
3.280
52 WEEK LOW
0.5100
MARKET CAP
141.99M
P/E (TTM)
-3.4953
1D
5D
1M
3M
1Y
5Y
1D
Connect Biopharma Price Target Announced at $9.00/Share by Lake Street
Dow Jones · 3d ago
Lake Street Initiates Coverage On Connect Biopharma Hldgs with Buy Rating, Announces Price Target of $9
Benzinga · 3d ago
Connect Biopharma initiated with a Buy at Lake Street
TipRanks · 3d ago
Weekly Report: what happened at CNTB last week (1124-1128)?
Weekly Report · 3d ago
Connect Biopharma Holdings to Present at Evercore Healthcare Conference
Reuters · 11/24 14:00
Weekly Report: what happened at CNTB last week (1117-1121)?
Weekly Report · 11/24 10:41
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 11/19 21:07
Connect Biopharma Reports Significant Loss Amid Development Efforts
TipRanks · 11/18 04:07
More
About CNTB
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company. The Company is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The Company has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.

Webull offers Connect Biopharma Holdings Ltd (ADR) stock information, including NASDAQ: CNTB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNTB stock methods without spending real money on the virtual paper trading platform.